Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Total 13F shares
-
10,345,548
-
Share change
-
-1,324,582
-
Total reported value
-
$9,310,000
-
Price per share
-
$0.90
-
Number of holders
-
10
-
Value change
-
-$901,419
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2020
As of 30 Jun 2020,
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,345,548 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Telemetry Investments, L.L.C., BRIDGEWAY CAPITAL MANAGEMENT INC, Berman Capital Advisors, LLC, WEDBUSH SECURITIES INC, MORGAN STANLEY, Winslow, Evans & Crocker, Inc., and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.